ArticleCellular and molecular life sciences : CMLS2026
Stella safeguards proteostasis via regulating UBE2D3 translation in the maternal-to-zygotic transition.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Ubiquitin-proteasome-mediated protein degradation is essential for maternal-to-zygotic transition, yet the maternal factors that safeguard ubiquitin-proteasome function remain unclear. Here, using a Stella-mutant mouse model, we demonstrate that Stella is required for global protein ubiquitination during early embryogenesis. Stella deficiency in oocytes leads to reduced ubiquitinated protein levels, impaired zygotic genome activation, and early developmental arrest. Proteomic and functional analyses identify UBE2D3 as the key E2 enzyme whose insufficiency underlies the ubiquitination defect. Mechanistically, Stella preserves YBX3 stability, thereby enabling YBX3-dependent translation of Ube2d3 mRNA. Consequently, Stella depletion destabilizes YBX3, diminishes UBE2D3 synthesis, and disrupts protein ubiquitination. Notably, overexpression of Ybx3 or Ube2d3 partially restores ubiquitinated protein levels, zygotic genome activation, and embryo development. These findings identify a previously unrecognized Stella-YBX3-UBE2D3 axis that ensures efficient maternal protein ubiquitination and zygotic genome activation, revealing a cytoplasmic mechanism by which maternal Stella governs proteostasis during maternal-to-zygotic transition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.